4.7 Article

Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection

Journal

VACCINES
Volume 9, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/vaccines9070741

Keywords

influenza; hemagglutinin; pseudotype; vaccine; immunogenicity; monoclonal anti-body; neutralization

Funding

  1. Bill and Melinda Gates Foundation [G101404]
  2. Innovate UK
  3. UK Research and Innovation (UKRI) [105078]
  4. EC FETopen [899619]
  5. Department of Science and Technology of South Africa [P10000029]
  6. UK Department for the Environment, Food and Rural Affairs (Defra)
  7. Scottish government [SE2213]
  8. Welsh government [SE2213]
  9. Innovate UK [105078] Funding Source: UKRI

Ask authors/readers for more resources

A library of influenza hemagglutinin (HA) pseudotypes was developed for use in influenza neutralization assays, demonstrating high sensitivity and specificity for detecting virus-specific neutralizing antibodies and assessing antibody functionality. These HA pseudotypes can serve as substitutes for wildtype viruses in experiments and are valuable for evaluating cross-subtype immune responses elicited by vaccines.
We developed an influenza hemagglutinin (HA) pseudotype library encompassing Influenza A subtypes HA1-18 and Influenza B subtypes (both lineages) to be employed in influenza pseudotype microneutralization (pMN) assays. The pMN is highly sensitive and specific for detecting virus-specific neutralizing antibodies against influenza viruses and can be used to assess antibody functionality in vitro. Here we show the production of these viral HA pseudotypes and their employment as substitutes for wildtype viruses in influenza neutralization assays. We demonstrate their utility in detecting serum responses to vaccination with the ability to evaluate cross-subtype neutralizing responses elicited by specific vaccinating antigens. Our findings may inform further preclinical studies involving immunization dosing regimens in mice and may help in the creation and selection of better antigens for vaccine design. These HA pseudotypes can be harnessed to meet strategic objectives that contribute to the strengthening of global influenza surveillance, expansion of seasonal influenza prevention and control policies, and strengthening pandemic preparedness and response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available